A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy - Van Geest, R J; Lesnik-Oberstein, S Y; Tan, H S (Br J Ophthalmol, 2012)